|

Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK

RECRUITINGSponsored by Grupo Espanol de Investigacion en Sarcomas
Actively Recruiting
SponsorGrupo Espanol de Investigacion en Sarcomas
Started2019-06-30
Est. completion2026-09-30
Eligibility
Age18 Years – 120 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04181970

Summary

Post-authorisation, multicentric, observational, retrospective and prospective study to assess quality of care of sarcoma patients in expert and non-expert centers by analysing correlation of quality items and outcomes such as relapse free survival, overall survival, percentage of amputation, etc. Expert pathology peer review will be performed to detect differences between expert and non-expert centers as well as differences in treatment and patient prognosis. Tumor samples of 4 types of sarcoma would also be included in translational research to detect biomarkers and produce preclinical models.

Eligibility

Age: 18 Years – 120 YearsHealthy volunteers accepted
Inclusion Criteria:

* Histological diagnosis of soft-tissue sarcoma, GIST or bone sarcoma (all subtypes) from January 2005 until Juny/September 2023.
* ≥ 18 years
* Available clinical and treatment information

Exclusion Criteria:

There is no exclusion criteria

Conditions4

Bone SarcomaCancerGastrointestinal Stromal TumorsSoft Tissue Sarcoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.